Ishita Drugs: No FY26 Fundraising, SEBI 32(1) Non-Applicable

Ishita Drugs & Industries Ltd files a compliance disclosure with BSE confirming non-applicability of SEBI Regulation 32(1).
The company confirms it did not raise any funds via public, rights, preferential issues, or QIP in FY ended March 2026.
Consequently, no statement of deviation or variation is required to be submitted for the stated financial period.